# Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation

> **NCT02404467** · — · COMPLETED · sponsor: **Institut für Pharmakologie und Präventive Medizin** · enrollment: 502 (actual)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DEVICE:** TF TAVI

## Key facts

- **NCT ID:** NCT02404467
- **Lead sponsor:** Institut für Pharmakologie und Präventive Medizin
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2018-11
- **Final completion:** 2019-07
- **Target enrollment:** 502 (ACTUAL)
- **Last updated:** 2020-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02404467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02404467, "Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02404467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
